CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Biogen Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


Return On Equity (Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Equity Change -19.89 % -23.21 % -12.82 % -9.3 % -
Y / Y Net Income Change -75.17 % -54.47 % 7.52 % -1.15 % 52.37 %
Net Income (TTM) in Millions 4,061 5,143 5,985 5,872 5,889
Return On Equity (TTM) 35.89 % 42.94 % 46.79 % 44.47 % 43.54 %
Total Ranking # 260 # 197 # 168 # 181 # 253
Equity (TTM) in Millions 10,686 10,745 11,289 12,537 13,339
Seq. Equity Change -0.54 % -4.82 % -9.95 % -6.01 % -4.66 %
Seq. Net Income Change -49.21 % -56.18 % 15.36 % -3.27 % -6.87 %


Roe Comment
Biogen Inc returned in IV. Quarter 35.89 % on shareholder's equity, and it was higher than Biogen Inc average return on equity.

ROE decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 50 other companies have achieved higher return on equity. While Return on equity total ranking has deteriorated compare to previous quarter from 199 to 260.

What is ROE?
Return On Equity Company Ranking
Within: No.
Industry # 11
Sector # 51
Overall # 260

Return On Equity Statistics
High Average Low
46.79 %
22.47 %
0.5 %
(Jun 30 2020)   (June 30. 2006)


Annual Return On Equity (Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
(Dec 31 2016)
2016
Total Equity in Millions 10,686 13,339 13,032 12,598 12,129
Y / Y Equity Change -19.89 % 2.36 % 3.44 % 3.87 % 29.37 %
Net Income in Millions 4,061 5,889 4,474 2,670 3,696
Y / Y Net Income Change -31.04 % 31.62 % 67.56 % -27.75 % 2.85 %
Return On Equity 38 % 44.14 % 34.33 % 21.19 % 30.47 %





Annual Roe Comment
In 2020 ROE decreased compare to previous year to 38 %, due to detoriation of net income.


Financial Statements
Biogen Inc 's Equity $ 10,686 Millions BIIB's Balance sheet
Biogen Inc 's Income $ 358 Millions Quarterly BIIB's Income Statement
BIIB's Income by Division See BIIB's Income by Division

More Return On Equity Ratios
Biotechnology & Drugs Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
BIIB's Roe Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for BIIB's Competitors
Return On Equity for Biogen Inc 's Suppliers
Roe for BIIB's Customers

You may also want to know
BIIB's Roa BIIB's Inventory Turnover Ratio BIIB's Growth Rates BIIB's Dividend Statistics
BIIB's Annual Roe BIIB's Profitability Ratios BIIB's Asset Turnover Ratio BIIB's Dividend Growth
BIIB's Roi BIIB's Valuation Ratios BIIB's Financial Strength Ratios BIIB's Dividend Payout Ratio



Companies with similar Return On Equity at Dec 31 2020, within Healthcare Sector ROE
Co diagnostics Inc   97.45 %
Quidel Corp  95.36 %
Fulgent Genetics Inc   92.70 %
Check cap Ltd  84.54 %
Integrated Biopharma Inc  79.22 %
Vascular Biogenics Ltd   78.35 %
Antares Pharma Inc   76.08 %
National Research Corporation  73.09 %
Retractable Technologies Inc  72.15 %
Amgen Inc   71.72 %
Semler Scientific Inc   66.17 %
Galmed Pharmaceuticals Ltd   65.16 %
Align Technology inc   59.37 %
Infusystem Holdings Inc  58.57 %
Coherus Biosciences inc   58.30 %
Innoviva inc   57.57 %
Surface Oncology Inc   56.37 %
Sage Therapeutics Inc   56.13 %
The Cooper Companies Inc   55.95 %
Catalyst Pharmaceuticals Inc   55.84 %
Hologic Inc  53.41 %
Siga Technologies Inc  53.02 %
Oramed Pharmaceuticals Inc   52.25 %
Abbvie inc   51.78 %
Davita Inc   51.09 %
Apollo Medical Holdings Inc   50.64 %
Zoetis Inc   49.88 %
Zomedica Corp   49.75 %
Elite Pharmaceuticals Inc  48.48 %
Bio rad Laboratories Inc   47.06 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MTEX's Profile

Stock Price

MTEX's Financials

Business Description

Fundamentals

Charts & Quotes

MTEX's News

Suppliers

MTEX's Competitors

Customers & Markets

Economic Indicators

MTEX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071